Crossmark

Icosapent ethyl: From the REDUCE-IT trial to clinical practice

Crossref DOI link: https://doi.org/10.1016/j.artere.2025.500820

Published Print: 2025-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Pedro-Botet, Juan
License Information

Text and Data Mining valid from 2025-07-01

Text and Data Mining valid from 2025-07-01

Version of Record valid from 2025-07-02
More Information

This article is maintained by: Elsevier

Article Title: Icosapent ethyl: From the REDUCE-IT trial to clinical practice

Journal Title: Clínica e Investigación en Arteriosclerosis (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.artere.2025.500820

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.arteri.2025.500820

Content Type: article

Copyright: © 2025 The Author. Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Arteriosclerosis.